Arcutis Biotherapeutics, Inc., founded in 2016, is a biopharmaceutical company that focuses on developing meaningful innovation in the treatment of immune-me-diated skin disease. With extensive dermatology development expertise and a deep understanding of what really matters to patients and healthcare professionals, Arcutis challenges the existing standard of care. With a lack of topical innovation spanning over the last 20 years, it’s Arcutis’ belief that patients deserve better, and the company strives to simplify disease management and optimize drug efÿcacy, safety, and tolerability.
The company has experienced impressive growth in a short amount of time, both from an employee base and business perspective, starting from a team of three employees from its inception to expanding to a team of over 280 today. Of the current employee base, 95% of Arcutis employees believe it is a great place to work compared to 57% of employees at a typical US-based company. The company has reported the diversity of the Board of Directors, with 40% of the board comprised of women and 40% from under-represented racial and ethnic groups. Arcutis is committed to diversity and inclusion in its hiring practices, with 32% of its leadership team comprised of women and 28% of its leadership team from under-represented racial and ethnic groups.
For Arcutis, diversity and inclusion also mean health equity. The company is committed to providing affordable access to therapy through responsible pricing and patient support and assistance programs. To further promote a diverse and inclusive culture, the company created the Arcutis Culture Team, a cross-section of employees throughout various levels and functions to integrate and facilitate the education of Arcutis employees and provide opportunities to strengthen their employee community. Since 2020, the Arcutis Culture Team has been engaged to plan, coordinate, and communicate employee engagement opportunities.